205 related articles for article (PubMed ID: 21278152)
1. Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery.
Solomon C; Budde U; Schneppenheim S; Czaja E; Hagl C; Schoechl H; von Depka M; Rahe-Meyer N
Br J Anaesth; 2011 Apr; 106(4):494-500. PubMed ID: 21278152
[TBL] [Abstract][Full Text] [Related]
2. Acquired von Willebrand syndrome in congenital heart disease surgery: results from an observational case-series.
Icheva V; Nowak-Machen M; Budde U; Jaschonek K; Neunhoeffer F; Kumpf M; Hofbeck M; Schlensak C; Wiegand G
J Thromb Haemost; 2018 Nov; 16(11):2150-2158. PubMed ID: 29908036
[TBL] [Abstract][Full Text] [Related]
3. Severe Aortic Valve Stenosis.
Frank RD; Lanzmich R; Haager PK; Budde U
Clin Appl Thromb Hemost; 2017 Apr; 23(3):229-234. PubMed ID: 27481874
[TBL] [Abstract][Full Text] [Related]
4. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.
Natorska J; Bykowska K; Hlawaty M; Marek G; Sadowski J; Undas A
Heart; 2011 Dec; 97(24):2023-8. PubMed ID: 21561895
[TBL] [Abstract][Full Text] [Related]
5. The Von Willebrand Factor Antigen Plasma Concentration: a Monitoring Marker in the Treatment of Aortic and Mitral Valve Diseases.
Perrone MA; Viola FG; Minieri M; Caporali S; Copponi A; Sancesario G; Angeletti S; Massoud R; Romeo F; Bernardini S; Terrinoni A
Folia Biol (Praha); 2020; 66(4):133-141. PubMed ID: 33745260
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding.
Casonato A; Sponga S; Pontara E; Cattini MG; Basso C; Thiene G; Cella G; Daidone V; Gerosa G; Pagnan A
Thromb Haemost; 2011 Jul; 106(1):58-66. PubMed ID: 21544311
[TBL] [Abstract][Full Text] [Related]
7. The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor.
Holdright DR; Hunt BJ; Parratt R; Segal H; Clarke D; Taggart D; Bennett G; Collins P
Eur J Cardiothorac Surg; 1995; 9(1):18-21. PubMed ID: 7727141
[TBL] [Abstract][Full Text] [Related]
8. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation.
Marggraf O; Schneppenheim S; Daubmann A; Budde U; Seiffert M; Reichenspurner H; Treede H; Blankenberg S; Diemert P
J Invasive Cardiol; 2014 Dec; 26(12):654-8. PubMed ID: 25480995
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
[TBL] [Abstract][Full Text] [Related]
10. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement.
Spangenberg T; Budde U; Schewel D; Frerker C; Thielsen T; Kuck KH; Schäfer U
JACC Cardiovasc Interv; 2015 Apr; 8(5):692-700. PubMed ID: 25946442
[TBL] [Abstract][Full Text] [Related]
12. A comparative in vitro evaluation of six von Willebrand factor concentrates.
Lethagen S; Carlson M; Hillarp A
Haemophilia; 2004 May; 10(3):243-9. PubMed ID: 15086321
[TBL] [Abstract][Full Text] [Related]
13. Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery.
Feldmann C; Zayat R; Goetzenich A; Aljalloud A; Woelke E; Maas J; Tewarie L; Schmitz-Rode T; Autschbach R; Steinseifer U; Moza A
PLoS One; 2017; 12(2):e0171029. PubMed ID: 28234916
[TBL] [Abstract][Full Text] [Related]
14. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor.
Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O
Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884
[TBL] [Abstract][Full Text] [Related]
15. Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices.
Egger C; Maas J; Hufen T; Schmitz-Rode T; Steinseifer U
Artif Organs; 2013 Sep; 37(9):833-9. PubMed ID: 23834027
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic pulmonary arterial hypertension - a unrecognized cause of high-shear high-flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children.
Pelland-Marcotte MC; Humpl T; James PD; Rand ML; Bouskill V; Reyes JT; Bowman ML; Carcao MD
Br J Haematol; 2018 Oct; 183(2):267-275. PubMed ID: 30141279
[TBL] [Abstract][Full Text] [Related]
17. Relatively increased von Willebrand factor activity after off-pump coronary artery bypass graft surgery.
Lo B; Nierich AP; Kalkman CJ; Fijnheer R
Thromb Haemost; 2007 Jan; 97(1):21-6. PubMed ID: 17200766
[TBL] [Abstract][Full Text] [Related]
18. Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement.
Bolliger D; Dell-Kuster S; Seeberger MD; Tanaka KA; Gregor M; Zenklusen U; Tsakiris DA; Filipovic M
Br J Anaesth; 2012 May; 108(5):754-62. PubMed ID: 22311365
[TBL] [Abstract][Full Text] [Related]
19. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
Meyer AL; Malehsa D; Bara C; Budde U; Slaughter MS; Haverich A; Strueber M
Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome.
Karger R; Weippert-Kretschmer M; Budde U; Kretschmer V
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
